Publikationen in Zusammenarbeit mit Forschern von Dana–Farber Cancer Institute (11)

2023

  1. Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage

    Frontiers in Oncology, Vol. 13

2021

  1. Genetic architectures of proximal and distal colorectal cancer are partly distinct

    Gut, Vol. 70, Núm. 7, pp. 1325-1334

2020

  1. Mendelian randomization analysis of n-6 polyunsaturated fatty acid levels and pancreatic cancer risk

    Cancer Epidemiology Biomarkers and Prevention, Vol. 29, Núm. 12, pp. 2735-2739

2019

  1. Development and validation of circulating CA125 prediction models in postmenopausal women

    Journal of Ovarian Research, Vol. 12, Núm. 1

  2. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1)

    Nature Communications

2018

  1. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

    Nature Communications, Vol. 9, Núm. 1

  2. Germline variation at 8q24 and prostate cancer risk in men of European ancestry

    Nature Communications, Vol. 9, Núm. 1

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

2012

  1. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11

    Human Molecular Genetics, Vol. 21, Núm. 24, pp. 5373-5384

2010

  1. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians

    Human Molecular Genetics, Vol. 19, Núm. 15, pp. 3089-3101

2006

  1. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)

    Breast Cancer Research, Vol. 8, Núm. 5